EMR
51
-2
ESS
33
2
MO
45
-2
GS
62
3
MAC
53
2
GM
57
-6
DVA
47
-4
CSCO
57
3
SJM
19
2
VRSN
66
4
PH
60
-2
PBI
42
-4
PSX
70
-4
CME
59
4
IBM
67
3
IR
35
-3
AMZN
42
-2
MCO
56
3
MDLZ
34
4
IRM
47
3
EMR
51
-2
ESS
33
2
MO
45
-2
GS
62
3
MAC
53
2
GM
57
-6
DVA
47
-4
CSCO
57
3
SJM
19
2
VRSN
66
4
PH
60
-2
PBI
42
-4
PSX
70
-4
CME
59
4
IBM
67
3
IR
35
-3
AMZN
42
-2
MCO
56
3
MDLZ
34
4
IRM
47
3
Financhill
Back

BioAtla, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

BCAB
BioAtla, Inc.

Last Price:
$0.13
Seasonality Move:
-4.48%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and BCAB is experiencing selling pressure, which indicates risk of future bearish movement.

BioAtla, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.15 Sell
20-day SMA: 0.16 Sell
50-day SMA: 0.19 Sell
200-day SMA: 0.49 Sell
8-day EMA: 0.15 Sell
20-day EMA: 0.12 Buy
50-day EMA: 0.07 Buy
200-day EMA: 0.02 Buy

BioAtla, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 36.45 Sell
Chaikin Money Flow: -518822 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.15 - 0.19) Sell
Bollinger Bands (100): (0.15 - 0.75) Sell

BioAtla, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioAtla, Inc. Stock

Is BioAtla, Inc. Stock a Buy?

  • BioAtla, Inc. share price is 0.13 while BCAB 8-day simple moving average is 0.15, which is a Sell signal.
  • The stock price of BCAB is 0.13 while BioAtla, Inc. 20-day SMA is 0.16, which makes it a Sell.
  • BioAtla, Inc. 50-day simple moving average is 0.19 while BCAB share price is 0.13, making it a Sell technically.
  • BCAB stock price is 0.13 and BioAtla, Inc. 200-day simple moving average is 0.49, creating a Sell signal.

BCAB Technical Analysis vs Fundamental Analysis

Sell
23
BioAtla, Inc. (BCAB) is a Sell

Is BioAtla, Inc. a Buy or a Sell?

  • BioAtla, Inc. stock is rated a Sell
    The current BioAtla, Inc. [BCAB] share price is $0.13. The Score for BCAB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.

BioAtla, Inc. Stock Info

Market Cap:
10.4M
Price in USD:
0.13
Share Volume:
1.1M

BioAtla, Inc. 52-Week Range

52-Week High:
1.43
52-Week Low:
0.12
Sell
23
BioAtla, Inc. (BCAB) is a Sell

BioAtla, Inc. Share Price Forecast

  • What is the BioAtla, Inc. stock price today?
    The BioAtla, Inc. stock price is 0.13 USD today.
  • Will BCAB stock go up or go down?
    BioAtla, Inc.> share price is forecast to RISE/FALL based on technical indicators
  • Is BioAtla, Inc. overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioAtla, Inc. is overvalued.

Is BioAtla, Inc. Stock a Buy?

  • BioAtla, Inc. share price is 0.13 while BCAB 8-day exponential moving average is 0.15, which is a Sell signal.
  • The stock price of BCAB is 0.13 while BioAtla, Inc. 20-day EMA is 0.12, which makes it a Buy.
  • BioAtla, Inc. 50-day exponential moving average is 0.07 while BCAB share price is 0.13, making it a Buy technically.
  • BCAB stock price is 0.13 and BioAtla, Inc. 200-day simple moving average is 0.02, creating a Buy signal.

Fundamental Analysis of BioAtla, Inc.

Is BioAtla, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.00 per share.

Technical Analysis of BioAtla, Inc.

Should I short BioAtla, Inc. stock?

* BioAtla, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.